To determine whether A20 could differentially contribute to glioma biology through the recently identified glioma subfractions, we utilized several complementary methods to evaluate A20 expression in freshly isolated GSC-enriched and -depleted cultures derived using our previously published methodology [11],[12],[15],[21],[23],[25]. The gene discussed is TNFAIP3; the disease is glioma.